Genetic immunotherapy for cancer

被引:7
作者
Elmslie, RE [1 ]
Dow, SW [1 ]
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, DIV BASIC IMMUNOL, DENVER, CO 80206 USA
来源
SEMINARS IN VETERINARY MEDICINE AND SURGERY-SMALL ANIMAL | 1997年 / 12卷 / 03期
关键词
D O I
10.1016/S1096-2867(97)80033-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
The application of gene therapy to the treatment of human and veterinary diseases offers an innovative addition to the clinician's treatment options. Gene therapy can potentially be used to (1) replace defective or missing genes, (2) treat cancer, and (3) deliver drugs. The focus of this paper is the use of gene therapy in the treatment of cancer. To be effective, genes must be delivered to target cells which can then serve as the factory to produce the gene product. Delivery systems include retroviral vectors, adenoviral vectors, and direct introduction of plasmid DNA into cells. In the case of cancer immunotherapy, introduced genes produce products that enhance tumor immunosurveillance and tumor cell killing by immune mechanisms. Copyright © 1997 by W.B. Saunders Company.
引用
收藏
页码:193 / 205
页数:13
相关论文
共 93 条